ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD

iShares Nasdaq US Biotechnology UCITS ETF - USD

ETF

BTEK

IE00BYXG2H39

Market Closed - London S.E. Other stock markets 11:35:04 2024-04-25 am EDT			5-day change	1st Jan Change
5.89 ^USD	-2.02%		-0.93%	-7.68%

2023	IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Declares Interim Dividend, Payable on 29 December 2023	CI
2022	IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Declares Interim Dividend, Payable on 30 December 2022	CI

IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces Interim Distribution for the Financial Year 2020, Payable on 23 December 2020

December 03, 2020 at 02:00 am EST

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF announced interim distribution of USD 0.0035 for the financial year 2020. Ex-date is 10 December 2020. Record date is 11 December 2020. Payment date is 23 December 2020.

All the latest ETF news

Record $8.8 bln pulled from US sustainable funds in Q1	Apr. 25	RE
US SEC expected to deny spot ether ETFs next month, industry sources say	Apr. 25	RE
IShares Premium Money Market ETF Announces Final April 2024 Cash Distribution, Payable on April 30, 2024	Apr. 24	CI
Hong Kong spot crypto ETFs to start trading next week	Apr. 24	RE
IShares Public Limited Company - iShares MSCI Europe ex-UK GBP Hedged UCITS ETF Announces Interim Distribution for the Year 2024, Payable on 15 May 2024	Apr. 24	CI
Franklin Templeton launches two ETFs	Apr. 24	FI
Fund offering 'venture capital' exposure sends investors on meme-like ride	Apr. 23	RE
Middlefield Real Estate Dividend ETF Announces Distributions for Second Quarter of 2024, Payable on May 15, 2024, June 14, 2024 and July 15, 2024	Apr. 23	CI

More news

Description

	IE00BYXG2H39
Total Expense Ratio	0.35%
Asset Class	Equities
Sector	Biotechnology Pharmaceuticals
Size	No restriction
Currency	USD
Provider	iShares
Underlying	NASDAQ Biotechnology Net Total Return Index - USD

Features and characteristics

Jurisdiction	Ireland
Replication Method	Direct (Physical)
Replication Model	Full Replication
Date of creation	2017-10-18
Dividend Policy	Capitalization
Geographical Focus	United States

Distribution

Retail investor
Qualified Investor

AuM evolution ( 2024-03-27 )

AuM (EUR)	443 M€
AuM 1M	426 M€
AuM 3 months	406 M€
AuM 6 months	364 M€
AuM 12 months	426 M€